John Boockvar, MD
Northwell Health · Feinstein Institute for Medical Research/Lenox Hill Hospital · Lenox Hill Hospital-Northwell Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
14
all conditions, ClinicalTrials.gov
NIH grants tied to them
9
NIH RePORTER
Trial papers in glioblastoma
0
PubMed author-name match
Trials
Studies that name John Boockvar, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:13 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05979064 · Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)Northwell Health · recruiting · Glioma, Glioma, Malignant, Glioblastoma · principal investigator
- N/ANCT05954858 · Surgical Tissue Flap to Bypass the Blood Brain Barrier in GlioblastomaNorthwell Health · recruiting · Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme · principal investigator
- Ph3NCT05271240 · Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBMNorthwell Health · recruiting · Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant · principal investigator
- Ph1NCT04222309 · Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)Northwell Health · suspended · Glioma, Glioma, Malignant, Glioblastoma · principal investigator
- N/ANCT03630289 · Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBMNorthwell Health · completed · Glioblastoma, Glioblastoma Multiforme, GBM · principal investigator
- Ph1/Ph2NCT03213002 · Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBMNorthwell Health · recruiting · Glioblastoma Multiforme (GBM), Glioblastoma, Glioma of Brain · principal investigator
- Ph2NCT02800486 · Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOANorthwell Health · recruiting · Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma · principal investigator
- Ph1NCT02438995 · Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and NeckNorthwell Health · terminated · Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck · principal investigator
- Ph1/Ph2NCT01811498 · Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBMNorthwell Health · completed · Glioblastoma Multiforme, Brain Tumor · principal investigator
- Ph1/Ph2NCT01386710 · Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic AstrocytomaNorthwell Health · suspended · Glioblastoma Multiforme, Anaplastic Astrocytoma · principal investigator
- Ph1/Ph2NCT01269853 · Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AANorthwell Health · recruiting · Glioblastoma Multiforme, Anaplastic Astrocytoma · principal investigator
- Ph1NCT01238237 · Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AANorthwell Health · completed · Glioblastoma Multiforme (GBM), ANAPLASTIC ASTROCYTOMA (AOA), GBM · principal investigator
- Ph1NCT01083966 · Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular SchwannomaNorthwell Health · suspended · Vestibular Schwannoma · principal investigator
- Ph1NCT00968240 · Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)Northwell Health · completed · Glioblastoma Multiforme, Anaplastic Astrocytoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- UNM Human Subjects Research Enhancement ProgramS07RR018187 · NCRR · UNIVERSITY OF NEW MEXICO · fiscal years 2002 · $150,000 awarded in 2002Same name and institution; not confirmed by an ID
- VITAMIN D P450 FUNCTION--NATURAL & DIRECTED MUTAGENESISR01AR045455 · NIAMS · UNIVERSITY OF NEW MEXICO · fiscal years 1998 to 2002 · $255,525 awarded in 2002Same name and institution; not confirmed by an ID
- ETHNIC VARIABILITY IN AN ETHANOL-INDUCIBLE P450 ENZYMER01AA008990 · NIAAA · UNIVERSITY OF NEW MEXICO · fiscal years 1994 · $209,947 awarded in 1994Same name and institution; not confirmed by an ID
- RENAL 25-(OH)D-HYDROXYLASES--ISOLATION AND MOLECULAR ASPECTSS06GM008139 · NIGMS · UNIVERSITY OF NEW MEXICO · fiscal years 1990 to 1991Same name and institution; not confirmed by an ID
- PROPHET II WORKSTATIONR24RR004380 · NCRR · UNIVERSITY OF NEW MEXICO · fiscal years 1987 · $16,897 awarded in 1987Same name and institution; not confirmed by an ID
- CELLULAR AND MOLECULAR MECHANISM OF VITAMIN AND HORMONE ACTIONS06RR008139 · NCRR · UNIVERSITY OF NEW MEXICO · fiscal years 1985Same name and institution; not confirmed by an ID
- HUMAN AGING AND VITAMIN D NUTRITIONM01RR000997 · NCRR · UNIVERSITY OF NEW MEXICO · fiscal years 1985Same name and institution; not confirmed by an ID
- HUMAN AGING AND VITAMIN D NUTRITIONR01AG003498 · NIA · UNIVERSITY OF NEW MEXICO · fiscal years 1985 · $81,170 awarded in 1985Same name and institution; not confirmed by an ID
- RENAL 25-(OH)D-HYDROXYLASES: ISOLATION, MOLECULAR ASPECTR01AM032280 · NIADDK · UNIVERSITY OF NEW MEXICO · fiscal years 1985 · $88,872 awarded in 1985Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.